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Giardiasis is a common diarrheal disease worldwide caused by the protozoan parasite
Giardia intestinalis. It is urgent to develop novel drugs to treat giardiasis, due to
increasing clinical resistance to the gold standard drug metronidazole (MTZ). New
potential antiparasitic compounds are usually tested for their killing efficacy against G.
intestinalis under anaerobic conditions, in which MTZ is maximally effective. On the
other hand, though commonly regarded as an ‘anaerobic pathogen,’ G. intestinalis
is exposed to relatively high O2 levels in vivo, living attached to the mucosa of the
proximal small intestine. It is thus important to test the effect of O2 when searching
for novel potential antigiardial agents, as outlined in a previous study [Bahadur et al.
(2014) Antimicrob. Agents Chemother. 58, 543]. Here, 45 novel chalcone derivatives
with triazolyl-quinolone scaffold were synthesized, purified, and characterized by high
resolution mass spectrometry, 1H and 13C nuclear magnetic resonance and infrared
spectroscopy. Efficacy of the compounds against G. intestinalis trophozoites was tested
under both anaerobic and microaerobic conditions, and selectivity was assessed in a
counter-screen on human epithelial colorectal adenocarcinoma cells. MTZ was used as
a positive control in the assays. All the tested compounds proved to be more effective
against the parasite in the presence of O2, with the exception of MTZ that was less
effective. Under anaerobiosis eighteen compounds were found to be as effective as
MTZ or more (up to three to fourfold); the same compounds proved to be up to >100-
fold more effective than MTZ under microaerobic conditions. Four of them represent
potential candidates for the design of novel antigiardial drugs, being highly selective
against Giardia trophozoites. This study further underlines the importance of taking O2
into account when testing novel potential antigiardial compounds.
Keywords: chemical synthesis, drug screening, anaerobic protozoa, intestinal disease, microaerobiosis
Introduction
The amitochondriate protozoon Giardia intestinalis is a human parasite, causing extensive
morbidity worldwide (Ankarklev et al., 2010). Approximately 6–8% of children and 2%
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of adults are estimated to be infected in urbanized countries
around the world (Craun, 1996). In spite of its recognition as
an important human pathogen for a long time, nearly 5,000
people are hospitalized with giardiasis annually in the United
States (see (Lengerich et al., 1994; Gardner and Hill, 2001) and
references therein). The disease spreads through fecal-oral trans-
mission of the parasite cysts (Adam, 2001). The host is typically
infected through ingestion of cyst-contaminated water or food.
After exposure to the acidic environment of the stomach lumen,
the cyst develops into the trophozoite, the vegetative form of the
parasite, that in turn attaches to the mucosa of the proximal small
intestine. This is the crucial step in establishing and maintain-
ing the infection. In the small intestine, the trophozoite starts
proliferating, causing symptoms like diarrhea, malabsorption,
dehydration, weight loss, failure to thrive, and chronic fatigue.
Following encystation, the parasite is ready to be expelled into
the environment and infect a new host, thus completing the life
cycle.
Giardiasis is commonly treated with several approved med-
ications, that include metronidazole (MTZ), tinidazole, fura-
zolidone, albendazole, paromomycin, or nitazoxanide (Ali
and Nozaki, 2007; Tejman-Yarden and Eckmann, 2011). This
notwithstanding, because of the limited eﬃcacy, heavy side
eﬀects, and increasing resistance of the parasite to available
treatments, it is mandatory to continue searching for novel anti-
giardial drug candidates (Upcroft and Upcroft, 2001; Ali and
Nozaki, 2007). The gold standard drug against giardiasis is MTZ,
(Edwards, 1993), a pro-drug that needs to be activated intra-
cellularly by reduction of the nitro moiety (Edwards, 1993).
Relevant to this study, by reaction with O2 the active form
of MTZ is converted back to the inactive parent compound.
Presence of O2 in the epithelium of the proximal small intes-
tine (Espey, 2013), where Giardia trophozoites adhere with their
ventral disks, is therefore expected to signiﬁcantly decrease the
eﬃcacy of MTZ in vivo. Given the fairly aerobic environment
inhabited by Giardia in the host, it is important to consider
possible eﬀects of O2, when testing novel potential antigiar-
dial drugs. Following this rationale, we have recently carried
out a study (Bahadur et al., 2014) in which a set of syn-
thetic compounds has been initially screened for its antigiardial
activity under anaerobic condition, and then the compounds
with the highest activity were assayed for their eﬃcacy under
microaerobic conditions too. This innovative approach allowed
us to identify two chalcone derivatives that under microaero-
bic conditions proved to be selectively active against Giardia
trophozoites and more eﬀective than MTZ (Bahadur et al.,
2014).
Nowadays, molecular hybridization is a coherent strategy
that allows one to design new chemical entities of poten-
tial biomedical relevance by fusing two or more recognized
active compounds and/or pharmacophoric units of known
bioactive molecules (Viegas-Junior et al., 2007; Walsh and
Bell, 2009). In this regard, chalcone derivatives linked to a
triazolyl-quinolone moiety represent an attractive drug scaf-
fold. Nitrogen containing heterocycles are indeed widely used
for the synthesis of compounds of pharmaceutical interest
(Syam et al., 2012) and chalcone analogs with their relatively
simple structure have a wide variety of pharmacological activ-
ities, largely attributed to their α,β unsaturated ketone moiety
(Kumar et al., 2003). Moreover, quinoline (1-azanaphthalene)
compounds are widely used as “parental” compounds to syn-
thesize molecules with a broad range of biological activities
including anti-inﬂammatory (el-Gazzar et al., 2009), antileish-
manial (Palit et al., 2009), antifungal (Kategaonkar et al.,
2010), and antituberculosis (Eswaran et al., 2010). Finally, tia-
zoles represent another important class of heterocycles because
of their varied biological activities and, accordingly, triazole-
containing ring systems are found in numerous existing drugs,
like ﬂuconazole, itraconazole, and voriconazole, commonly used
as anti-inﬂammatories, CNS-stimulants, sedatives, antianxiety,
antimicrobials, and antimycotics (Shaker, 2006; Saadeh et al.,
2010).
Here, we have synthesized, puriﬁed and thoroughly character-
ized a set of 45 novel chalcone analogs with triazolyl-quinolone
scaﬀold, and comparatively evaluated their antigiardial activity
both in anaerobiosis and microaerobiosis. This led to the iden-
tiﬁcation of four compounds poorly toxic against human cells,
yet able to aﬀect Giardia trophozoites more eﬀectively than MTZ
under both anaerobic and microaerobic conditions.
Materials and Methods
Materials
All chemicals used in the synthesis of chalcones analogs were
purchased from Sigma–Aldrich and Fluka and were used
as such without any prior puriﬁcation. MTZ, ATP, peni-
cillin/streptomycin, bovine calf serum, bovine bile, and the chem-
icals for the Diamond’s TYI-S-33 medium used for Giardia
cell cultures were purchased from Sigma–Aldrich. Fetal bovine
serum, glutamine, non-essential amino acids, trypsin-EDTA, and
the Eagle’sMinimum Essential Medium (EMEM)were purchased
from GIBCO (Life technologies). Other chemicals and solvents
purchased locally were of analytical grade. Caco-2 cells (ATCC R©
HTB-37TM) were purchased from Sigma–Aldrich. Incubation
bags for anaerobiosis (Anaerocult R© Aminisystem) and microaer-
obiosis (Anaerocult R© C minisystem) were from Merck. Sterile
96-well white clear-bottom plates were purchased from Perkin
Elmer. The ATP one-step luminescence assay systems for micro-
bial (BacTiter-GloTM) and human (ATPliteTM) cells were from
Promega and Perkin Elmer, respectively.
Synthesis and Characterization of
Chalcones
Chemical Methods
Homogeneity/purity of all the products was analyzed by thin-
layer chromatography (TLC) on alumina coated plates (Merck).
Product samples in MeOH were loaded on TLC plates and
developed in CHCl3–MeOH (9.8:0.2, v/v). On detection of
slight impurities by iodine vapor/UV light visualization, com-
pounds were further puriﬁed by chromatography on silica
gel columns (100–200 mesh size, CDH), using petroleum
ether-ethyl acetate (3:2, v/v) as the eluent. Melting points
were determined in open glass capillary tubes on a Buchi
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M-560 instrument and are uncorrected. Infrared (IR) spectra
were recorded in KBr medium using a Perkin-Elmer Fourier
Transform-IR spectrometer, whereas 1H and 13C nuclear mag-
netic resonance (NMR) spectra were recorded in CDCl3 medium
on a JNM ECX-400P (JEOL, USA) spectrometer with tetram-
ethylsilane (TMS) as internal reference. IR and NMR spec-
tra were recorded at the Department of Chemistry, University
of Delhi, India. Absorption frequencies (ν) are expressed in
cm−1, chemical shifts in ppm (δ-scale) and coupling con-
stants (J) in Hz. Splitting patterns are described as singlet
(s), doublet (d), triplet (t), quartet (q), and multiplet (m).
High resolution mass spectroscopy (HRMS) data were col-
lected with a resolution of 10,000 on a KRATOS MS50TC
spectrometer and a Kratos Mach III type at the University
of Leuven (KU Leuven, Celestijnenlaan 200F, 3001 Leuven,
Belgium).
General Procedure for the Synthesis of
2-chloroquinoline-3-carbaldehyde (Ramesh et al.,
2008) (2)
2-chloroquinoline-3-carbaldehyde was synthesized from
acetanilide (1) via a Vilsmeier–Haack reaction by traditional
methods. To a well-stirred mixture of N,N-dimethylformamide
(DMF, 3 equiv.) and acetanilide 1 (1 equiv.), POCl3 (12 equiv.)
was added dropwise slowly at 0◦C. Afterward the reaction
mixture was heated to 100◦C for 16 h and the reaction progress
was monitored by TLC. After completion of the reaction, the
mixture was allowed to cool down to room temperature and
poured into crushed ice under vigorous stirring. The obtained
precipitate was ﬁltered, washed with water and re-crystallized
from dry EtOH to give the title compound 2 with 62% yield; mp
146–147◦C (lit 148◦C).
General Procedure for the Synthesis of
2-oxoquinoline-3-carbaldehyde (Ramesh et al.,
2008) (3)
2-chloroquinoline-3-carbaldehyde 2 was reﬂuxed in 70% acetic
acid to obtain 2-oxoquinoline-3-carbaldehyde 3. The reaction
mixture was heated to 110◦C for 12 h and the reaction progress
wasmonitored by TLC.After completion of the reaction, themix-
ture was allowed to cool down to room temperature and poured
into crushed ice under vigorous stirring. The obtained precipi-
tate was ﬁltered, washed with water and re-crystallized from dry
EtOH to give the title compound 3with 90% yield; mp 301–302◦C
(lit 304◦C).
General Procedure for the Synthesis of 2-oxo-1-
(prop-2-ynyl)-1,2-dihydroquinoline-3-carbaldehyde
(Pal et al., 2011) (4)
To a solution of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde 3
(1.0 equiv.) in K2CO3 (1.5 equiv.) and DMF, propargyl bromide
(1.5 equiv) was added dropwise. The reaction mixture was stirred
at room temperature for 12 h. After completion of the reaction,
the mixture was poured into ice-cooled water. The solid sepa-
rated was ﬁltered, washed, dried, and re-crystallized from ethanol
to give the title compound 4 with 75% yield; mp 195–197◦C (lit
198◦C).
General Procedure for the Synthesis of Azidobenzene
and its Derivatives (Haridas et al., 2011) (5–9)
To a mixture of appropriate aniline (1 equiv.) in 17% HCl
stirred at 0◦C, aqueous sodium nitrite (1.2 equiv.) was added
dropwise with continued stirring for 10 min at 0◦C. Afterward,
aqueous sodium azide (1.2 equiv.) was added dropwise to the
reaction mixture at 0◦C with continued stirring for additional
3 h at room temperature. The reaction progress was monitored
by TLC [petroleum ether/ethyl acetate (5:1)]. After completion of
the reaction, the mixture was subjected to extraction with ethyl
acetate (2 × 25 mL). The combined organic layer was dried over
Na2SO4 and concentrated under reduced pressure, to obtain an
oily brown colored compound.
General Procedure for the Synthesis of
2-oxo-1-((1-phenyl-1H-1,2,3-triazol-4-yl)methyl)-1,2-
dihydroquinoline-3-carbaldehyde (10–14)
The mixture of alkyne 4 (1 equiv.), appropriate azide (5–9;
1.5 equiv.), CuSO4·5H2O (0.2 equiv.), and sodium ascorbate
(0.4 equiv.) was taken in a (3:1) mixture of tetrahydrofuran
(THF) and water and stirred at room temperature for 12 h. The
reaction progress was monitored by TLC using CHCl3: MeOH
(9.7:0.3, v/v) as the solvent system. After completion of the reac-
tion, the mixture was subjected to extraction with ethyl acetate
(3 × 30 mL). The combined ethyl acetate layer was dried over
Na2SO4 concentrated under reduced pressure and ﬁnally puri-
ﬁed by silica gel (100–200 mesh size) column chromatography
using petroleum ether – ethyl acetate (3:2) as the eluent to yield
the desired product.
General Procedure for the Synthesis of (E)-3-(3-oxo-
3-phenylprop-1-en-1-yl)-1-((1-phenyl-1H-1,2,3-
triazol-4-yl)methyl)quinolin-2(1H)-one (23–67).
To a solution of aryl ketone (15–22; 1 equiv.) and triazolyl-
quinaldehyde (10–14; 1 equiv.) in dry MeOH, cat. sodium
hydroxide was added. The resulting reaction mixture was stirred
at room temperature for 24 h. The reaction progress was mon-
itored by TLC using CHCl3:MeOH (9.8:0.2, v/v) as the solvent
system. After completion of the reaction, the mixture was poured
into ice-cool water. The obtained colored precipitate was ﬁltered
and dried on vacuum. The compounds were ﬁnally puriﬁed by
silica gel (100–200 mesh size) column chromatography using
petroleum ether – ethyl acetate (3:2) as the eluent.
Assays on Cells
Cell Cultures
Trophozoites of G. intestinalis strain WB clone C6 (ATCC No.
50803TM) were cultured axenically at 37◦C in 25-cm2 ﬂasks con-
taining Diamond’s TYI-S-33 medium supplemented with 10%
bovine calf serum, 1 mg/mL bovine bile, 0.1 g/L streptomycin
and 100 U/mL penicillin. Typically, 50 ml medium was inocu-
lated with 25 × 106 cells and after 2 days cells were harvested
by chilling the ﬂasks on ice for 30 min for drug susceptibil-
ity assays. Human epithelial colorectal adenocarcinoma (Caco-2)
cells were grown in 25-cm2 ﬂasks in EMEM supplemented with
1% (v/v) non-essential amino acids, 2 mM glutamine, 5% (v/v)
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fetal bovine serum, 0.1 g/L streptomycin, and 100 U/mL peni-
cillin.
Assays on Giardia trophozoites
The assays were performed following the procedure described in
Bahadur et al. (2014), using sterile 96-well white clear-bottom
plates. In each well, 50 μL of Giardia trophozoites at a den-
sity of 1 × 105 cells/mL was added to 50 μL medium con-
taining either the compound to be tested, serially diluted from
a stock solution in dimethyl sulfoxide (DMSO), or the same
amount of DMSO as a control; this yielded a ﬁnal density of
5.000 cells/100 μL in each well. Each drug concentration was
tested in at least six replicates. MTZ was used as an inter-
nal positive control in the assay. The microtiter plates were
then incubated at 37◦C under anaerobic or microaerobic con-
ditions, ensured by the Anaerocult R© A or the Anaerocult R© C
minisystem (Merck), respectively. According to themanufacturer
instructions, the Anaerocult R© A minisystem produces anaerobic
conditions within ∼1 h, whereas the Anaerocult R© C minisys-
tem generates microaerobic conditions (∼5% O2) within 24 h.
Following 48 h incubation with the compound to be tested,
100 μL of the BacTiter-GloTM Microbial Cell Viability Assay
System reagent (Promega) was added to each well for one-step
lysis and ATP level detection. Plates were then incubated at
room temperature for 15 min and ATP levels ﬁnally detected by
luminescence on a plate reader (Wallac Victor3 1420 Multilabel
Counter, PerkinElmer).
Assays on Caco-2 Cells
Cells were detachedwith 0.5% trypsin-EDTA and seeded in sterile
96-well white clear-bottom plates at the same density of Giardia
trophozoites and at increasing concentration of the compound
to be tested, as described above. The assays were carried out
exactly as reported for the Giardia trophozoites, except that the
plates were incubated (still at 37◦C) at atmospheric O2 level, 5%
CO2, and 95% humidity. Each drug concentration was tested in
at least seven replicates. MTZ was used as an internal negative
control in the assay. Following 48 h incubation with each com-
pound, according to the manufacturer instructions, 100 μL of
the ATPliteTM luminescence assay system (Perkin Elmer) was
added to each well for one-step lysis and ATP level detection by
luminescence.
Determination of Half-Maximal Inhibitory
Concentration (IC50) and Selectivity Index (SI)
Luminometric data were calibrated using ATP standard curves
and normalized to the ATP level measured in control
DMSO-treated cells (taken as 100%). The measured ATP
level percentage was plotted as a function of the com-
pound concentration and the half-maximal inhibitory con-
centration (IC50) was obtained by ﬁtting the resulting titra-
tion proﬁle to the Hill equation (Goutelle et al., 2008).
The selectivity index (SI) of the compounds was then cal-
culated as the ratio between the IC50 value measured on
human cells over the value determined on Giardia trophozoites
(SI = IC50,Caco−2/IC50,Giardia).
Results
Synthesis of Novel Triazolyl-Quinolone
Based Chalcones
Forty-ﬁve novel triazolyl-quinolone-based chalcone derivatives
were synthesized based on previously described Claisen-Schmidt
condensation (Li et al., 1995), according to the synthetic
route outlined in Figure 1. Intermediate triazolyl-quinolone
compounds 10–14 were synthesized at room temperature in
THF:water with 50–75% yield, by “click chemistry” (Barral et al.,
2007) of the synthesized alkyne 4 with appropriate aromatic
azides (5–9), using CuSO4·5H2O and sodium ascorbate as cat-
alysts. As shown in Figure 1, compounds 23–67 were obtained
at room temperature by reaction of the intermediate compounds
10–14 with commercially available aromatic acetophenones 15–
22, in the presence of NaOH in dryMeOH. After puriﬁcation, the
yield of products 23–67 ranged from 60 to 95%.
The newly synthesized triazolyl-quinolone-based chalcone
derivatives were characterized by HRMS, 1H and 13C NMR and
IR spectroscopy, and relevant data are reported in Supplementary
Material.
Antigiardial Activity of the Synthesized
Chalcones
The antigiardial activity of the novel compounds 23–67 was
tested under both anaerobic and microaerobic conditions.
According to (Dunn et al., 2010; Bahadur et al., 2014), sus-
ceptibility of Giardia trophozoites to increasing concentrations
of each compound was assessed based on ATP level determi-
nation by luminescence. Dose-response curves for each com-
pound were obtained after 48 h-incubation and compared to the
data collected under identical conditions with MTZ, the drug
of choice for treatment of giardiasis. In these assays, the ATP
level measured in control Giardia trophozoites grown under
microaerobic conditions was found to be approximately 25%
lower than in the same cells grown under anaerobic condi-
tions, and DMSO at concentrations ≤2%v/v caused onlymarginal
eﬀects on cell ATP levels. Typical dose-response curves are shown
in Figure 2, whereas the IC50 values measured for the syn-
thetic compounds and MTZ under anaerobic and microaerobic
conditions are reported in Table 1. In agreement with the liter-
ature (Müller et al., 2006), under the experimental conditions of
the assay, MTZ proved to be highly eﬀective (IC50 = 3.4 μM)
against Giardia parasites in the absence of O2, but remarkably
less (IC50 ≥ 25 μM) under microaerobic conditions. Under
anaerobic conditions, 18 out of the 45 synthetic compounds
were as eﬀective as MTZ or more under identical conditions
(see Table 1). Among them, compounds 41, 43, and 45 dis-
played the highest activity, being three to fourfold more eﬃcient
than MTZ.
Interestingly, at variance fromMTZ, all the tested compounds
displayed a higher eﬃcacy against Giardia under microaer-
obic conditions than in the absence of O2. Notably, apart
from a few exceptions (namely, compounds 23 and 58), due
to their enhanced eﬃcacy and the notably lower activity of
MTZ, all the screened compounds were found to be more
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FIGURE 1 | Synthetic route to compounds 23–67. (a) DMF, POCl3, 0–100◦C, 16 h; (b) 70% acetic acid, 110◦C, 12 h; (c) K2CO3, DMF, rt, 12 h; (d) CuSO4·5H2O,
Na-ascorbate, THF:H2O (3:1), rt, 12 h; (e) NaOH, MeOH, rt, 24 h.
eﬀective than MTZ under microaerobic conditions. In many
cases, the eﬀect of O2 was remarkable, as it can be seen from
the IC50 values reported in Table 1. Under microaerobic con-
ditions approximately half of the tested compounds proved to
be at least ﬁvefold more active against Giardia than in the
absence of O2. The eﬀect of O2 was particularly evident in
the case of compounds 24, 31, 49, and 51, which displayed
≥10-fold higher activities under microaerobic conditions than
measured in anaerobiosis. Interestingly, up to 10 compounds dis-
played IC50 ≤ 0.5 μM under microaerobic conditions, thereby
becoming >50-fold more active than MTZ under identical
conditions.
Selectivity of the Synthetic Compounds
Selectivity of the newly synthesized compounds toward Giardia
was assessed by running a counter-screen on human epithe-
lial Caco-2 cells. Similarly to the screen carried out on Giardia
trophozoites, dose-response curves and corresponding IC50
values for each compound were obtained after 48 h-incubation,
as reported above. This allowed us to calculate the compounds
SI, deﬁned as the ratio between the IC50 value measured on
human cells over the value determined on Giardia trophozoites.
In the assays on human cells, DMSO aﬀected ATP cell levels only
slightly (up to 10% at ≤ 2%v/v, not shown) and, as expected,
MTZ exhibited a high IC50 value (>100 μM). Interestingly,
under the same experimental conditions, 19 compounds were
only poorly eﬀective against human cells, being characterized by
IC50 values≥40 μM (Table 1). Among these, compounds 29, 39,
65, and 66 were particularly interesting in that they proved to be
(i) more eﬀective than MTZ against Giardia trophozoites both in
anaerobiosis (IC50 ranging from 2.2 to 3.2 μM) and microaer-
obiosis (IC50 ranging from 0.4 to 1.6 μM), and (ii) much less
eﬀective on human cells (IC50 ≥ 40 μM), thereby exhibiting
a high selectivity toward Giardia trophozoites (with SI values
exceeding 15 and 30 under anaerobiosis and microaerobiosis,
respectively).
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FIGURE 2 | Effect of metronidazole (MTZ) and compound 65 on Giardia
trophozoites. Dose-response curves of MTZ (A) and the newly synthesized
compound 65 (B), measured on Giardia trophozoites cultured under
anaerobic (closed symbol) or microaerobic (open symbol) conditions. Data are
expressed as mean ± SEM (n ≥ 6).
Discussion
Compared to other more distal tracts of the gut, the proxi-
mal small intestine is a fairly aerobic environment, where O2
is supplied mostly by the submucosal vascular network and
in part with swallowed air (Dawson et al., 1965; Levitt, 1970;
Sheridan et al., 1990; He et al., 1999). In this tract of the gut,
O2 concentration is relatively high and subjected to sudden
oscillations, particularly in the postprandial period when the
metabolic demand increases upon transit of partly processed
food (Espey, 2013). Relevant to the present study, O2 concentra-
tion is particularly high at the level of the intestinal epithelium,
where trophozoites of G. intestinalis adhere with their ventral
disks. O2 tension indeed decreases along a steep gradient from
80–100 to nearly 0 mm Hg, moving inward from the submu-
cosa toward the luminal midpoint (Espey, 2013). Therefore,
though commonly regarded as an anaerobic protozoon, Giardia
is likely exposed to fairly high and variable O2 levels in vivo.
The parasite is amitochondriate and thus unable to utilize O2
to sustain energy metabolism. This notwithstanding, μM O2
concentrations have been shown to produce profound changes
in the metabolism of Giardia trophozoites, leading to stim-
ulation of both ethanol and CO2 production, elicited oxida-
tion of the intracellular NAD(P)H pool and reduced alanine
production (Paget et al., 1993). In addition to these adaptive
metabolic changes, in order to survive oxidative stress condi-
tions, Giardia needs to activate the antioxidant defense sys-
tem (Brown et al., 1995; Mastronicola et al., 2011; Raj et al.,
2014). In this regard, it has been established that, though lack-
ing bona ﬁde catalases or superoxide dismutases, Giardia is
endowed with several alternative antioxidant enzymes that have
been recently identiﬁed and partly characterized. These include:
a NADH oxidase (Brown et al., 1996a) and a ﬂavodiiron pro-
tein (Di Matteo et al., 2008; Vicente et al., 2009) detoxifying
O2 to H2O, a ﬂavohemoglobin converting nitric oxide into
nitrate (Mastronicola et al., 2010, 2011; Raﬀerty et al., 2010),
a superoxide reductase promptly degrading superoxide anion
to H2O2 (Testa et al., 2011), a thioredoxin reductase (Brown
et al., 1996b) and two peroxiredoxins (Mastronicola et al., 2014)
implicated in peroxide detoxiﬁcation and repair of oxidatively
damaged molecules. Exposure to O2 is therefore expected to
cause notable changes in the metabolic and proteomic proﬁle
of G. intestinalis, an aspect that has not been studied in detail
thus far.
Despite being physiologically exposed to O2 in vivo, Giardia
trophozoites are commonly assayed in vitro for their drug
susceptibility under anaerobic conditions. This may bias the
results of a screening. Leading to changes in cell metabolism,
O2 may indeed modify the susceptibility of the parasite to
speciﬁc drugs, possibly up- or down-regulating molecular tar-
gets. Moreover, by directly reacting with the tested drugs,
it may alter their mechanism of action, possibly leading to
enhanced or reduced eﬃcacy. This is the case of MTZ, the
gold standard drug against giardiasis, whose eﬃcacy is abol-
ished upon reaction of its nitro-radical active form with
O2 (Edwards, 1993). When testing new potential antigiar-
dial drugs, it is thus important to take O2 into account also
to attempt identifying antiparasitic compounds that could be
fully eﬀective under the more physiological microaerobic con-
ditions in which MTZ eﬃcacy is reduced due to O2 pres-
ence. This issue has been highlighted in a recent study by
our groups (Bahadur et al., 2014) in which O2, while mak-
ing MTZ expectedly less eﬀective, was reported to enhance
the eﬃcacy of three piperidine/piperazine chalcone deriva-
tives, pre-selected in a screen conducted under anaerobic
conditions.
In the present study, 45 novel chalcone derivatives with
triazolyl-quinolone scaﬀold were synthesized, puriﬁed, and char-
acterized by HRMS, 1H and 13C NMR and IR spectroscopy.
As an innovative approach, all the compounds were compara-
tively tested for their eﬃcacy against G. intestinalis trophozoites
under both anaerobic andmicroaerobic conditions. Compared to
anaerobic conditions, the presence of O2 was found to increase
the IC50 of MTZ from 3.4 to ≥25 μM. This result agrees with
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TABLE 1 | Chemical identity, IC50 values and selectivity index (SI) of the novel synthetic compounds.
Giardia
(anaerobiosis)
Giardia
(microaerobiosis)
Caco-2 Selectivity
(IC50,Caco/IC50,Giardia)
S. No R R1 R2 R3 IC50 IC50 IC50 Anaerobiosis Microaerobiosis
23 OMe F H H ≥100 ≥20 ≥100 n.d. n.d.
24 OMe H F H ≥100 8,4 ≥50 n.d. ≥6
25 OMe H H F 3,9 1,3 ≥20 ≥ 5 ≥15
26 OMe H H Cl 5,0 2,6 ≥20 ≥4 ≥7
27 OMe H H Br 9,6 2,0 ≥20 ≥2 ≥10
28 OMe H H Me 5,4 1,5 ≥80 ≥14 ≥53
29 OMe OMe H H 2,2 0,4 ≥40 ≥18 ≥100
30 OMe H OMe H 5,9 1,3 ≥200 ≥33 ≥153
31 OMe H H OMe ≥50 2,0 ≥80 n.d. ≥40
32 Me F H H 3,2 0,6 17,6 5,5 29,3
33 Me H F H 4,0 0,7 13,4 3,4 19,1
34 Me H H F 3,8 1,2 9,4 2.5 7.8
35 Me H H Cl 2,4 0,8 7,0 2.9 8.8
36 Me H H Br 10,7 2,3 ≥50 ≥4 ≥21
37 Me H H Me 6,3 1,6 ≥50 ≥7 ≥31
38 Me OMe H H 2,0 0,4 13,7 6,9 34,3
39 Me H OMe H 2,9 1,3 ≥100 ≥34 ≥76
40 Me H H OMe ≥15 2,4 ≥60 n.d. ≥25
41 F F H H 0,9 0,2 5,2 5,8 26
42 F H F H 3,3 0,7 9,6 2,9 13,7
43 F H H F 1,2 0,3 7,0 5,8 23,3
44 F H H Cl 1,5 1,0 7,2 4.8 7,2
45 F H H Br 1,1 0,5 16,7 15,2 33,4
46 F H H Me 2,5 0,4 6,3 2,5 15,8
47 F OMe H H 2,7 0,3 ≥20 ≥7 ≥66
48 F H OMe H 7,0 1,6 ≥ 60 ≥8 ≥37
49 F H H OMe 13,0 1,3 ≥50 ≥3 ≥38
50 Cl F H H 4,7 0,9 ≥ 50 ≥10 ≥55
51 Cl H F H 10,0 0,9 ≥100 ≥10 ≥111
52 Cl H H F 8,9 1,2 23,9 2,7 19,9
53 Cl H H Cl 9,0 1,1 ≥30 ≥3 ≥27
54 Cl H H Br 9,2 1,9 ≥20 ≥ 2 ≥10
55 Cl H H Me 8,7 1,1 20 2,3 18,2
56 Cl OMe H H 3,2 0,6 8,4 2,6 14,0
57 Cl H OMe H 6,6 1,1 14,7 2,2 11,3
58 Cl H H OMe ≥100 ≥30 19,7 ≤0,2 ≤0,7
59 H F H H 1,9 0,4 11,2 5,9 28,0
60 H H F H 3,5 0,7 ≥50 ≥14 ≥71
61 H H H F 5,3 0,8 18,2 3,4 22,8
62 H H H Cl 2,1 0,7 5,9 2.8 8,4
63 H H H Br 6,3 1,0 ≥50 ≥ 7 ≥ 50
64 H H H Me 2,8 0,5 17,8 6,4 35,6
65 H OMe H H 1,6 0,4 ≥50 ≥31 ≥125
66 H H OMe H 3,2 1,6 ≥50 ≥15 ≥31
67 H H H OMe 5,9 0,8 ≥100 ≥16 ≥125
MTZ 3,4 ≥25 ≥100 ≥29.0 n.d.
Bold, IC50< IC50,MTZ in anaerobiosis; Compounds 29, 39, 65 and 66 display IC50 < IC50,MTZ in both anaerobiosis and microaerobiosis, low toxicity against Caco-2 cells
(IC50 ≥ 40.0) and SI > 10.
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the notion that O2 interferes with MTZ, by converting its nitro-
radical active form into the parental inactive form (Edwards,
1993). However, noteworthy, in spite of the reduced eﬃcacy
of MTZ, all the tested compounds proved to be more eﬀective
in the presence of O2, though to diﬀerent extent. For most of
the compounds the IC50 was four to sevenfold smaller than
measured under anaerobic conditions, but in the case of four
compounds (24, 31, 49, and 51) O2 was particularly eﬀec-
tive decreasing their IC50 by more than 10-fold. While under
anaerobic conditions only 18 out of the 45 tested compounds
proved to be as active as MTZ or more, in the presence
of O2 almost all the tested compounds (with the exception
of compounds 23 and 58) were more eﬀective than MTZ.
Under microaerobic conditions, up to 10 compounds showed
notably low IC50 values (≤0.5 μM), thereby becoming >50-
fold more eﬀective than MTZ under the same microaerobic
conditions, yet less eﬀective than the alternative antigiardial
drug albendazole that under anaerobic conditions shows very
low IC50 values (<0.1 μM, Cedillo-Rivera and Munoz, 1992).
Interestingly, 19 out of the 45 tested compounds displayed
very poor toxicity against human Caco-2 cells (IC50≥40 μM),
and by comparing their eﬃcacy on human and Giardia cells
10 out of these 19 compounds proved to be highly selec-
tive toward the parasite, being ≥10-fold more eﬀective against
Giardia under both anaerobic and microaerobic conditions.
Among these 10 compounds highly selective against Giardia,
four can be considered as hits to develop potential antigiar-
dial drugs, namely compounds 29, 39, 65, and 66, being more
eﬀective than MTZ under both anaerobic and aerobic condi-
tions.
The compounds characterized here carry substitutions in
two phenyl rings: ring A (attached to the triazole moiety) and
ring B (attached to the α,β unsaturated moiety). By inspect-
ing Table 1, it can be noted that on average the compounds
with the highest antigiardial activity have either unsubstituted
(compounds 59–67) or ﬂuoro-substituted (compounds 41–49)
ring A. Comparatively, less antigiardial activity is observed
when the same ring is substituted with chloro (compounds
50–58), methoxy (compounds 23–31) or methyl (compounds
32–40) groups. Compared to other types of substitutions in
ring A, the ﬂuoro-substitution seems to result into higher
toxicity of the compounds against human cells. The occur-
rence of substitutions at ring B and their position in the ring
also appear to modulate the antigiardial activity. Comparison
of compounds 29, 30, and 31 shows that the position of a
methoxy substituent in ring B has great eﬀects on the antipar-
asitic activity of the molecules. The ortho substituted com-
pound 29 is more eﬀective than the meta substituted com-
pound 30, that in turn displays a higher antigiardial activ-
ity compared to the para substituted analog (compound 31).
Interestingly, the same trend (ortho > meta > para) is invari-
ably observed by comparing the compound triplets 38–40, 47–
49, 56–58, and 65–67, all having methoxy-substituted ring B.
Finally, it is worth noticing that the compounds optimally com-
bining high antigiardial activity and low toxicity against human
cells (compounds 29, 39, 65, and 66) have ring B invariably
methoxy-substituted at ortho or meta positions, and ring A
either unsubstituted or substituted with methoxy or methyl
groups.
To the best of our knowledge, this is the ﬁrst study in which
a complete set of new synthetic compounds has been screened
for its ability to aﬀect Giardia trophozoites under both anaer-
obic and microaerobic conditions, providing unequivocal evi-
dence for an eﬀect of O2. The results show that, as compared
to anaerobic conditions, the presence of low, more physiolog-
ical O2 concentrations elicits the antiparasitic activity of the
tested compounds, while having opposite eﬀects on MTZ. The
molecular mechanism underlying the observed eﬀects of O2
has yet to be established. A possibility is that O2, by directly
aﬀecting Giardia trophozoites, on the one hand impairs MTZ
activation and on the other makes the cells more susceptible
to the novel synthetic drugs here described. A more intriguing
possibility is that, in response to O2 exposure, the parasite acti-
vates speciﬁc metabolic pathways that are selectively targeted
by the compounds tested in the present study, but not MTZ.
To address this issue, it would important in future studies to
acquire more detailed information on the pathways that are acti-
vated in Giardia in the metabolic transition from anaerobic to
microaerobic conditions.
Conclusion
In this study we have identiﬁed four new compounds that under
both anaerobic and more physiological microaerobic conditions
are highly eﬀective against Giardia trophozoites, targeting the
parasite selectively and more eﬃciently than MTZ. These four
synthetic chalcone derivatives represent potential candidates for
the design of novel antigiardial drugs. This work further high-
lights that it is important to take O2 into account when screening
new potential antigiardial drugs.
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